1,25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia

Kidney International

Volumn 53, Issue 5, 1998, Pages 1353-1357

  Mak, Robert H K ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

End stage renal disease; Glucose intolerance; Hemodialysis; Hypertriglyceridemia; Insulin resistance

Indexed keywords

CALCITRIOL; CHOLESTEROL; DIHYDROTACHYSTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; PARATHYROID HORMONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GLUCOSE INTOLERANCE; HEMODIALYSIS; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOINSULINEMIA; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS DRUG ADMINISTRATION; LIPID METABOLISM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; UREMIA;

EID: 0031816036     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00865.x     Document Type: Article

References (18)

1. DEFRONZO RA, ALVESTRAND A, SMITH D, HENDLER R, HENDLER E, WAHREN J: Insulin resistance in uremia. J Clin Invest 67:563-570, 1981
2. MAK RHK, DEFRONZO RA: Glucose and insulin metabolism in uremia. Nephron 61:377-382, 1992
3. CHAN MK, VARGHESE. Z, MOORHEAD JF: Lipid abnormalities in uremia, dialysis and transplantation. Kidney Int 19:625-637, 1981
4. DEFRONZO RA, SMITH D: Is glucose intolerance harmful for the uremic patient? Kidney Int 28(Suppl 17):S88-S96, 1985
5. NORMAN AW, FRANKEL BJ, HEDLT AM, GRODKSY GM: Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209:823-825, 1980
6. 3 improves glucose intolerance and insulin secretion in the vitamin D deficient rat in vivo. Endocrinology 119:84-90, 1986
7. MAK RHK: Renal disease, insulin resistance and glucose intolerance. Diabetes Rev 2:19-28, 1994
8. SLATOPOLSKY E, WERTS C, THIELAN J, HORST R, HARTER H, MARTIN KJ: Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 74:2136-2143, 1984
9. KAUTZKY-WILLER A, PACINI G, BARNAS U, LUDVIK B, STRELI C, GRAF H, PRAGER R: Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Int 47:200-206, 1995
10. DEFRONZO RA, TOBIN J, ANDRES R: Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
11. MCGUIRE EAH, HELDERMAN JH, TOBIN JD, ANDRES R, BERMAN M: Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41:565-573, 1976
12. MAK RHK, BETTINELLI A, TURNER C, HAYCOCK GB, CHANTLER C: The influence of hyperparathyroidism on glucose metabolism in uremia. J Clin Endocrinol Metab 60:229-234, 1985
13. MAK RHK, TURNER C, HAYCOCK GB, CHANTLER C: Secondary hyperparathyroidism and glucose tolerance in children with uremia. Kidney Int 24(Suppl 16):S128-S133, 1983
14. MASSRY SG, AKMAL M: Lipid abnormalities, renal failure and parathyroid hormone. Am J Med 87:42-44, 1989
15. MAK RHK: 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int 41:1048-1054, 1992
16. DEFRONZO RA, TOBIN JD, ROWE JW, ANDRES R: Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest 62:425-432, 1978.
17. MAK RHK: Insulin resistance in uremia: Effect of dialysis modality. Pediatr Res 40:304-308, 1996
18. APPEL G: Lipid abnormalities in renal disease. Kidney Int 39:169-183, 1991